The Ministry of Food and Drug Safety on the 3rd announced the approval of the new psoriasis drug Sotyktu (ingredient: deucravacitinib) imported by BMS Korea.Sotyktu is an oral psoriasis dr...
Starting this month, Sotyktu (deucravacitinib), an oral treatment for moderate-to-severe plaque psoriasis in adults, receives health insurance benefits in Korea for treating adult patients with chr...
Four Korean drugmakers have obtained approval for generic versions of Amgen's oral psoriasis treatment, Otezla (apremilast).Daewoong Pharmaceutical, DongKoo Bio&Pharma, Dong-A ST, and Chong Kun Dan...
WebMD explores different treatments for psoriasis.
A novel drug almost entirely cleared moderate to severe psoriasis in over 60% of the patients who took part in two phase three clinical trials of a new drug.The University of Manchester and Salford...
Psoriasis can last for years. Learn more about the types, symptoms, causes, and effective treatment options for psoriasis.
If you have moderate to severe psoriasis and your current treatment isn’t working, it may be time to think about using a biologic. Here’s what you need to know.
WebMD defines scalp psoriasis and explains its causes, symptoms, and treatments like special shampoos and conditioners.
Biologics are different from traditional systemic drugs that impact the entire immune system. Biologics only target specific parts of the immune system. The biologics used to treat psoriatic disease block the action of a specific type of immune cell called a T-cell. Or they block proteins in the immune system, such as tumor necrosis factor-alpha (TNF-alpha), interleukin 17-A, or interleukins 12 and 23. These cells and proteins all play a major role in developing psoriasis and psoriatic arthritis (PsA). ...
The good news is that plenty of treatment options exist. Plaque psoriasis is the most common type of psoriasis, a skin condition that causes red and silver thick, scaly patches of skin.1 · "Wearing your disease on the outside of your body can be very difficult, which is why it's wonderful that we have so many plaque psoriasis treatments that we can use to make people better," Robert T. Brodell, MD, chair of the department of dermatology at the University of Mississip ...